Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 523-526

  Fracasso, Paula M ^a   Blessing, John A ^b   Molpus, Kelly L ^c   Adler, Lisa M ^d   Sorosky, Joel I ^e   Rose, Peter G ^f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d Colorado Gynecologic Oncology Group PC ^*  (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Advanced endometrial cancer; Endometrial carcinoma; Oxaliplatin as second line chemotherapy; Oxaliplatin therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; OXALIPLATIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ANEMIA; ARTHRALGIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DIAPHORESIS; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG WITHDRAWAL; DYSESTHESIA; DYSPNEA; ENDOMETRIUM CARCINOMA; FEMALE; HEMATOLOGIC DISEASE; HEMATURIA; HUMAN; HYPOTENSION; INFECTION; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PAIN; PALLOR; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RIGOR; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; UROGENITAL TRACT DISEASE; VOMITING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS;

EID: 33750991326     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.043     Document Type: Article

References (16)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Lentz S.S. Advanced and recurrent endometrial carcinoma: hormonal therapy. Semin Oncol 21 (1994) 100-106
3. Muss H.B. Chemotherapy of metastatic endometrial cancer. Semin Oncol 21 (1994) 107-113
4. Rose P.G. Endometrial carcinoma. NEJM 335 (1996) 640-649
5. Steer C., and Harper P. Is there any place for cytotoxic chemotherapy in endometrial cancer?. Best Pract Res Clin Obstet Gynaecol 15 (2001) 447-467
6. Thigpen J.T., Blessing J.A., Homesley H.D., Creasman W.T., and Sutton G. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 33 1 (1989) 68-70
7. Thigpen J.T., Blessing J.A., Lagasse L.D., et al. Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Am J Clin Oncol 7 (1987) 253-256
8. Thigpen J.T., Brady M.F., Homesley H.D., et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 22 (2004) 3902-3908
9. Aapro M., Bolis G., Chevallier B., et al. An EORTC-GCCG randomized phase II trial of doxorubicin (dox) versus dox-cisplatin (CDDP) in endometrial carcinoma. Proc Am Soc Clin Oncol 13 (1994) 885a
10. Mani S., Graham M.A., Bregman D.B., Ivy P., and Chaney S.G. Oxaliplatin: a review of evolving concepts. Cancer Investig 20 (2002) 246-263
11. Raymond E., Faivre S., Chaney S., Woynarowski J., and Cvitkovic E. Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther 1 (2002) 227-235
12. DiFrancesco A.M., Ruggeriero A., and Riccardi R. Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci 59 (2002) 1914-1927
13. Extra J.M., Marty M., Brienza S., and Misset J.L. Pharmacokinetics and safety profile of oxaliplatin. Semin Oncol 25 (1998) 13-22
14. Misset J.L., Bleiberg H., Sutherland W., Bekradda M., and Cvitkovic E. Oxaliplatin clinical activity: a review. Crit Rev Oncol Hematol 35 (2000) 75-93
15. Chen T.T., and Ng T. Optimal flexible designs in phase II clinical trials. Stat Med 17 (1998) 2301-2312
16. Humber C., Tierney J., Symonds P., Collingwood M., Kirwan J., Williams C., et al. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. The Cochrane Database Syst Rev 4 (2005)